AS Latvijas Juras medicinas centrs
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It also involved in provision of other education services related activities. In addition, the… Read more
AS Latvijas Juras medicinas centrs (UOM) - Net Assets
Latest net assets as of September 2025: €6.32 Million EUR
Based on the latest financial reports, AS Latvijas Juras medicinas centrs (UOM) has net assets worth €6.32 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.87 Million) and total liabilities (€2.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €6.32 Million |
| % of Total Assets | 71.24% |
| Annual Growth Rate | -1.21% |
| 5-Year Change | 15.69% |
| 10-Year Change | N/A |
| Growth Volatility | 8.34 |
AS Latvijas Juras medicinas centrs - Net Assets Trend (2015–2024)
This chart illustrates how AS Latvijas Juras medicinas centrs's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AS Latvijas Juras medicinas centrs (2015–2024)
The table below shows the annual net assets of AS Latvijas Juras medicinas centrs from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €6.38 Million | +2.87% |
| 2023-12-31 | €6.20 Million | -8.85% |
| 2022-12-31 | €6.81 Million | +7.35% |
| 2021-12-31 | €6.34 Million | +14.94% |
| 2020-12-31 | €5.52 Million | +0.26% |
| 2019-12-31 | €5.50 Million | -0.55% |
| 2018-12-31 | €5.53 Million | -7.13% |
| 2017-12-31 | €5.96 Million | -14.59% |
| 2016-12-31 | €6.97 Million | -2.03% |
| 2015-12-31 | €7.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to AS Latvijas Juras medicinas centrs's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.62 Million | 41.11% |
| Other Components | €3.76 Million | 58.89% |
| Total Equity | €6.38 Million | 100.00% |
AS Latvijas Juras medicinas centrs Competitors by Market Cap
The table below lists competitors of AS Latvijas Juras medicinas centrs ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SOFINA (8FS.SG)
STU:8FS
|
$2.13 Million |
|
Gold Rock Holdings Inc
PINK:GRHI
|
$2.13 Million |
|
ED Invest S.A.
WAR:EDI
|
$2.13 Million |
|
Emerson Radio Corporation
NYSE MKT:MSN
|
$2.13 Million |
|
Glacier Lake Resources Inc
V:GLI
|
$2.13 Million |
|
PLACE HOLDINGS SD -05
F:95N
|
$2.13 Million |
|
Divio Technologies AB Series B
ST:DIVIO-B
|
$2.13 Million |
|
Thai Ha Public Company Limited
BK:KASET
|
$2.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AS Latvijas Juras medicinas centrs's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,203,573 to 6,381,781, a change of 178,208 (2.9%).
- Net income of 178,208 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €178.21K | +2.79% |
| Total Change | €- | 2.87% |
Book Value vs Market Value Analysis
This analysis compares AS Latvijas Juras medicinas centrs's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €7.29 | €7.40 | x |
| 2018-12-31 | €6.92 | €7.40 | x |
| 2019-12-31 | €6.88 | €7.40 | x |
| 2020-12-31 | €6.90 | €7.40 | x |
| 2021-12-31 | €7.93 | €7.40 | x |
| 2022-12-31 | €8.51 | €7.40 | x |
| 2023-12-31 | €7.75 | €7.40 | x |
| 2024-12-31 | €7.98 | €7.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AS Latvijas Juras medicinas centrs utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.75%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 1.42x
- Recent ROE (2.79%) is above the historical average (2.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -6.03% | -6.48% | 0.66x | 1.42x | €-998.00K |
| 2016 | -1.58% | -1.63% | 0.70x | 1.40x | €-718.81K |
| 2017 | 3.84% | 3.54% | 0.85x | 1.27x | €-359.40K |
| 2018 | 0.63% | 0.52% | 0.94x | 1.29x | €-518.62K |
| 2019 | 2.98% | 2.26% | 1.03x | 1.29x | €-386.05K |
| 2020 | 4.96% | 3.86% | 0.96x | 1.33x | €-278.07K |
| 2021 | 13.88% | 9.40% | 1.13x | 1.30x | €246.21K |
| 2022 | 9.19% | 6.45% | 1.10x | 1.30x | €-54.90K |
| 2023 | -10.06% | -6.34% | 1.09x | 1.46x | €-1.24 Million |
| 2024 | 2.79% | 1.75% | 1.12x | 1.42x | €-459.97K |
Industry Comparison
This section compares AS Latvijas Juras medicinas centrs's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,542,527,848
- Average return on equity (ROE) among peers: 7.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AS Latvijas Juras medicinas centrs (UOM) | €6.32 Million | -6.03% | 0.40x | $2.13 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| Garofalo Health Care S.p.A (GHC) | $333.14 Million | 6.51% | 1.55x | $126.70 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |